Puriblood Medical Co., Ltd. (TPEX:6847)

Taiwan · Delayed Price · Currency is TWD

49.90

+0.05 (0.10%)

At close: Apr 24, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
High-End Blood Purification Related Medical Equipment & Animal Blood Transfusion	110.67M	125.27M	137.44M	54.59M	38.65M
High-End Blood Purification Related Medical Equipment & Animal Blood Transfusion Growth	-11.65%	-8.86%	151.79%	41.25%	1149.06%
Total	110.67M	125.27M	137.44M	54.59M	38.65M
Total Growth	-11.65%	-8.86%	151.79%	41.25%	1149.06%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taiwan	100.79M	117.54M	132.61M	51.46M	35.75M
Taiwan Growth	-14.25%	-11.36%	157.71%	43.92%	-
Other	9.88M	7.72M	4.83M	3.13M	252.00K
Other Growth	27.90%	59.82%	54.41%	1142.06%	-
United States	-	-	-	-	2.64M
Total	110.67M	125.27M	137.44M	54.59M	38.65M
Total Growth	-11.65%	-8.86%	151.79%	41.25%	-

Source: S&P Global Market Intelligence.